CAP El Remei

Vic, Barcelona 08500

0 studies enrolling now · 1 studies all time

What they study most

Healthy

Studies at this site

• A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. — Completed